Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma

Exclusion Criteria

• •1 Present or present with other malignant tumors within 3 years prior to first use
• •2 Unalleviated toxicity above CTCAE grade 1 due to any prior treatment
• •3 Major surgical treatment and significant traumatic injury were performed within 28 days prior to initial administration
• •4 A wound or fracture that has not healed for a long time
• •5 Those who have a history of psychotropic drug abuse and can't get rid of it or have mental disorders
• •6 Subject with any severe and/or uncontrolled disease
• •7 Prior chemotherapy within 3 weeks prior to initial drug use, and prior radiotherapy or other antineoplastic drugs within 2 weeks prior to initial drug use
• •8 Those who have participated in and used other antitumor clinical trials within 4 weeks prior to the first drug use